intervention. Common signals include:

• Frequent Deviations: Increased instances of deviations from Standard Operating Procedures (SOPs) or established protocols can indicate systemic issues.
• Quality Escapes: Products failing quality control tests or exhibiting unexpected variability in specifications may reflect underlying non-compliance.
• Inspection Findings: Reports from health authorities including WHO, FDA, or EMA that outline concerns around quality management practices are critical indicators.
• Supplier Audit Results: Red flags raised during routine supplier audits should prompt an immediate review.

Likely Causes

Understanding the probable causes of WHO GMP non-compliance requires a structured approach to categorization. Here’s a breakdown of potential issues:

Materials

• Substandard raw materials or components not meeting WHO specifications.
• Lack of proper documentation or certificates of analysis (CoA).

Method

• Inconsistent application of validated methods resulting in erratic outcomes.
• Outdated or ineffective SOPs leading to improper practices.

Machine

• Equipment not calibrated or maintained according to GMP standards.
• Failure of equipment leading to product contamination or non-conformance.

Man

• Insufficient training or qualifications of personnel impacting product handling.
• Lack of adherence to hygiene or procedural compliance among staff.

Measurement

• Measurement inaccuracies due to improper calibration of instruments.
• Insufficient monitoring of environmental conditions affecting product quality.

Environment

• Inadequate control of manufacturing environments such as humidity and temperature.
• Contamination risks from improper facility design or cleanliness issues.

Immediate Containment Actions (first 60 minutes)

Upon identifying potential non-compliance, immediate containment is crucial. Actions should include:

• Halting production processes associated with the identified non-compliance.
• Securing affected products and materials in designated quarantine areas.
• Notifying all relevant stakeholders including Production, QA, and RA teams.
• Conducting a preliminary assessment to ascertain the scope of the issue.
• Documenting all preliminary findings and actions taken for audit readiness.

Investigation Workflow

A rigorous investigation must follow initial containment. Use the following steps to gather essential data:

Data to Collect

• Batch records and relevant quality control data.
• Training records of personnel involved in the affected processes.
• Maintenance logs for equipment used during the production.
• Environmental monitoring records for the involved areas.
• Supplier quality history and previous audit results.

Data Interpretation

After data collection, analyze to identify trends related to the non-compliance:

• Look for recurring issues across multiple batches or products.
• Assess whether the non-compliance is isolated or system-wide.
• Engage with cross-functional teams to gain insights on operational challenges.

Root Cause Tools

Employ the appropriate tools to determine root causes effectively. Here’s when to use each:

5-Why Analysis

The 5-Why technique is effective for simple problems requiring a direct and straightforward exploration of underlying issues. It promotes deeper questioning to get beyond symptoms.

Fishbone Diagram

Best utilized for complex issues involving multiple factors, the Fishbone (or Ishikawa) diagram enables visualization of various potential causes, providing a comprehensive view of contributory elements.

Fault Tree Analysis

This method is geared towards intricate systems, facilitating a top-down approach to examining combinations of failures leading to non-compliance. It’s effective when quantifying causes and understanding failure probabilities.

CAPA Strategy

Implementing a robust Corrective and Preventive Action (CAPA) plan is essential:

Correction

• Immediate correction of the specific issue, ensuring it doesn’t impact the ongoing production unnecessarily.
• Reassessment of impacted batches for quality evaluations.

Corrective Action

• Identify systematic failings contributing to the non-compliance.
• Implement changes in processes or training to prevent reoccurrences.

Preventive Action

• Engage in periodic reviews and audits to proactively identify risks.
• Strengthen supplier assessments and engagements to ensure compliance with WHO standards.

Control Strategy & Monitoring

A comprehensive control strategy is vital to ensure ongoing compliance. Key components include:

Related Reads

• Achieving QMS Compliance in the Pharmaceutical Industry
• Validation & Qualification Compliance in Pharmaceutical Manufacturing

Statistical Process Control (SPC)

Utilize SPC tools to monitor critical processes through control charts, ensuring processes remain in a state of control. Trending data should be reviewed regularly for anomalies.

Sampling Plans

• Establish random sampling protocols for verifying production quality.
• Implement risk-based sampling based on historical quality data.

Alarms and Alerts

Set up alarms for deviations in critical parameters. These should be integrated into monitoring systems to provide immediate notification to relevant personnel.

Verification Practices

Regularly verify the effectiveness of all implemented controls and quality measures, adjusting as necessary to reflect new data or compliance requirements.

Validation / Re-qualification / Change Control Impact

Understand when validation or re-qualification may be impacted:

• Significant changes in processes or materials may necessitate a re-validation to ensure compliance with WHO GMP standards.
• Engage in change control for any modifications resulting from the investigation findings, ensuring all alterations are documented and assessed for compliance implications.

Inspection Readiness: What Evidence to Show

To ensure inspection readiness, maintain thorough documentation and evidence including:

• Records and Logs: Maintain detailed logs of deviations, CAPA actions, and monitoring results.
• Batch Documentation: Ensure batch records are complete and reflect compliance assessments.
• Deviations: Document all deviations and the subsequent investigations for transparency during inspections.
• Training Records: Keep updated training records for all personnel involved in the affected processes.

FAQs

What steps should I take first when non-compliance is identified?

Immediately cease affected production processes and secure all products/materials for evaluation. Notify all relevant stakeholders to begin the investigation.

How can I ensure that our CAPA processes are effective?

Regularly review and assess CAPA effectiveness, adjusting actions based on the outcomes and emerging trends. Document all inputs and revisions for transparency.

What documentation is critical for inspection readiness?

Critical documentation includes deviation records, batch records, maintenance logs, and corrective action plans. Ensure all records are accessible and well organized.

How often should we conduct supplier audits?

Supplier audits should be conducted on a regular basis, based on risk assessments, with more frequent audits for higher-risk suppliers.

What role does training play in GMP compliance?

Training ensures that all personnel are aware of procedures and expectations, significantly contributing to compliance and quality assurance.

How can SPC tools help maintain compliance?

SPC tools aid in monitoring processes to detect deviations early, allowing for rapid intervention before larger compliance issues develop.

What is the difference between corrective and preventive action?

Corrective actions address existing problems, while preventive actions aim to reduce the likelihood of future occurrences by identifying and mitigating risks.

How do we assess if a change requires validation?

Any change that affects the quality or intended use of the product or process may require re-validation to ensure compliance with WHO standards.